An independent analysis by Magnolia Market Access estimates that changes proposed by NHIA to the Preserving Patient Access to Home Infusion Act to expand Medicare Part B home infusion therapy services coverage to anti-infectives, and bundle payments for disposable supplies with the services payment would generate significant savings for Medicare. Magnolia’s estimate for the supply bundling policy is consistent with the estimate that CBO has provided a savings of approximately $400 million over 10 years. On the IV anti-infective policy, Magnolia provides 2 savings estimates based on the magnitude of patients that would migrate from hospitals to home infusion under this coverage expansion: $500 million over 10 years if 25% of patients shift to home infusion, and $1 billion over 10 years if 50% of patients shift to home infusion.
The National Home Infusion Association has announced the finalists for its 2025 Exhibitor Innovation Award. The award recognizes groundbreaking products or services that advance the home and alternate site infusion industry.
NHIA announces two new companies will join its 2024-2025 Board of Directors. Board members serve 3-year terms as representatives for their NHIA member organization. Joining the NHIA Board of Directors are Pentec Health, represented by Matthew Deans, CEO and Vital Care Infusion Services, represented by Logan Davis, Executive VP of Trade Relations and Strategy. In addition to the newly installed members, Upstate Home Care, Froedtert Health, and Amerita were elected to additional terms.
The National Home Infusion Association (NHIA) is proud to announce that Mitra Gavgani, PharmD is the recipient of the 2025 Gene Graves Lifetime Achievement Award.
